New Drug Combination Lengthened Survival for Some with Lung Cancer
For Immediate Release – ASCO 2022 Abstract #9004 Contact: Frank DeSanto, Communications Manager, SWOG Cancer Research Network, fdesanto@swog.org, 210.718.2941 Ryan Hohman, JD, Vice President – Public Affairs, Friends of Cancer Research, rhohman@focr.org, 202.944.6708 Ramucirumab plus pembrolizumab combination reduced risk of death by 31 percent compared to standard of care in patients with advanced non-small cell lung cancer that had…
Spring 2022 Newsletter
Winter 2021 Newsletter
Fall 2021 Newsletter
Summer 2021 Newsletter
Spring 2021 Newsletter
Lung-MAP Translational Discoveries Shared at 2020 World Conference on Lung Cancer
For Immediate Release Contact: Wendy Lawton, Communications Manager, SWOG Cancer Research Network, lawtonw@ohsu.edu, 503-348-8675 Ryan Hohman, JD, Vice President – Public Affairs, Friends of Cancer Research, rhohman@focr.og 202.944.6708 Lung-MAP Translational Discoveries Shared at 2020 World Conference on Lung Cancer WASHINGTON, DC – Investigators leading the Lung Cancer Master Protocol, or Lung-MAP trial, will present findings from three translational medicine…